InVision

InVision provides digital medical technology and medical communication services.

Business Model:

Revenue: $0

Employees: 11-50

Detailed InVision Information

Geographic Data

InVision headquarters map

Address:

City: Xuhui

State: Shanghai

Zip:

Country: China

Financial Info

Stage:

angel

Raised Last:

$3M

Raised Total:

$3M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

InVision is a developer of digital technology in the medical industry designed to make medical information communication more convenient with VR technology. The company&s;s platform provides medical mobile application development, medical 3d production, and medical digital display, improving communication in the medical industry.

Contact Phone:

Contact Email:

InVision went public on 11/11/2016 on the NEEQ

Listed Exchange:
NEEQ

IPO Date:
11/11/2016

Ticker Symbol:
839661

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
3/2016 Angel Round 1 $3.1M Yueyin Venture Capital
Yueyin Venture Capital
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research